Berntorp E - Search Results

1

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030

2

Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia.

Ljung R, Petrini P, Lindgren AK, Berntorp E. Ljung R, et al. Among authors: berntorp e. Acta Paediatr. 1992 Nov;81(11):918-20. doi: 10.1111/j.1651-2227.1992.tb12135.x. Acta Paediatr. 1992. PMID: 1467614

3

Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies.

Björkman S, Carlsson M, Berntorp E, Stenberg P. Björkman S, et al. Among authors: berntorp e. Clin Pharmacokinet. 1992 May;22(5):385-95. doi: 10.2165/00003088-199222050-00005. Clin Pharmacokinet. 1992. PMID: 1505144

4

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Nilsson IM, et al. Among authors: berntorp e. J Intern Med. 1992 Jul;232(1):25-32. doi: 10.1111/j.1365-2796.1992.tb00546.x. J Intern Med. 1992. PMID: 1640190

5

Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate.

Berntorp E, Nilsson IM, Ljung R, Widell A. Berntorp E, et al. Lancet. 1990 Jun 23;335(8704):1531-2. doi: 10.1016/0140-6736(90)93075-z. Lancet. 1990. PMID: 1972463 No abstract available.

6

Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation.

Björkman S, Carlsson M, Berntorp E. Björkman S, et al. Among authors: berntorp e. Eur J Clin Pharmacol. 1994;46(4):325-32. doi: 10.1007/BF00194400. Eur J Clin Pharmacol. 1994. PMID: 7957517

7

Biochemical and in vivo properties of high purity factor IX concentrates.

Berntorp E, Björkman S, Carlsson M, Lethagen S, Nilsson IM. Berntorp E, et al. Thromb Haemost. 1993 Nov 15;70(5):768-73. Thromb Haemost. 1993. PMID: 8128433

8

Pharmacokinetic dosing in prophylactic treatment of hemophilia A.

Carlsson M, Berntorp E, Björkman S, Lindvall K. Carlsson M, et al. Among authors: berntorp e. Eur J Haematol. 1993 Oct;51(4):247-52. doi: 10.1111/j.1600-0609.1993.tb00638.x. Eur J Haematol. 1993. PMID: 8243614

9

Modern treatment of haemophilia.

Berntorp E, Boulyjenkov V, Brettler D, Chandy M, Jones P, Lee C, Lusher J, Mannucci P, Peak I, Rickard K, et al. Berntorp E, et al. Bull World Health Organ. 1995;73(5):691-701. Bull World Health Organ. 1995. PMID: 8846496 Free PMC article. Review.

10

[Antithrombin III concentrate seeks its therapeutic role. Be careful and wait for the results of the studies!].

Astermark J, Lethagen S, Berntorp E. Astermark J, et al. Among authors: berntorp e. Lakartidningen. 1996 Oct 23;93(43):3773-6, 3778. Lakartidningen. 1996. PMID: 8965549 Review. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters